Concepedia

Publication | Open Access

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease

DOIFull Paper Access

924

Citations

21

References

2020

Year

Sotirios Tsimikas, Ewa Karwatowska‐Prokopczuk, Ioanna Gouni‐Berthold, Jean‐Claude Tardif, Seth J. Baum, Elizabeth Steinhagen-Thiessen, Michael D. Shapiro, Erik S.G. Stroes, Patrick M. Moriarty, Børge G. Nordestgaard,
New England Journal of Medicine

Abstract

APO(a)-L<sub>Rx</sub> reduced lipoprotein(a) levels in a dose-dependent manner in patients who had elevated lipoprotein(a) levels and established cardiovascular disease. (Funded by Akcea Therapeutics; ClinicalTrials.gov number, NCT03070782.).

References

YearCitations

Page 1